204 related articles for article (PubMed ID: 21620836)
21. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases.
Hao B; Oehlmann S; Sowa ME; Harper JW; Pavletich NP
Mol Cell; 2007 Apr; 26(1):131-43. PubMed ID: 17434132
[TBL] [Abstract][Full Text] [Related]
22. [Function and mechanism of tumor suppressor gene FBW7 in tumorigenesis].
Huang HJ; Zheng F; Xu FP; Liu YH; Zhuang HG
Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):214-6. PubMed ID: 23769449
[No Abstract] [Full Text] [Related]
23. Mechanisms of tumor suppression by the SCF(Fbw7).
Minella AC; Clurman BE
Cell Cycle; 2005 Oct; 4(10):1356-9. PubMed ID: 16131838
[TBL] [Abstract][Full Text] [Related]
24. Serum- and glucocorticoid-inducible kinase 1 (SGK1) controls Notch1 signaling by downregulation of protein stability through Fbw7 ubiquitin ligase.
Mo JS; Ann EJ; Yoon JH; Jung J; Choi YH; Kim HY; Ahn JS; Kim SM; Kim MY; Hong JA; Seo MS; Lang F; Choi EJ; Park HS
J Cell Sci; 2011 Jan; 124(Pt 1):100-12. PubMed ID: 21147854
[TBL] [Abstract][Full Text] [Related]
25. Fbw7α and Fbw7γ collaborate to shuttle cyclin E1 into the nucleolus for multiubiquitylation.
Bhaskaran N; van Drogen F; Ng HF; Kumar R; Ekholm-Reed S; Peter M; Sangfelt O; Reed SI
Mol Cell Biol; 2013 Jan; 33(1):85-97. PubMed ID: 23109421
[TBL] [Abstract][Full Text] [Related]
26. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
27. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
28. CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.
Jin X; Yang C; Fan P; Xiao J; Zhang W; Zhan S; Liu T; Wang D; Wu H
J Biol Chem; 2017 Apr; 292(15):6269-6280. PubMed ID: 28242758
[TBL] [Abstract][Full Text] [Related]
29. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase.
Grim JE; Gustafson MP; Hirata RK; Hagar AC; Swanger J; Welcker M; Hwang HC; Ericsson J; Russell DW; Clurman BE
J Cell Biol; 2008 Jun; 181(6):913-20. PubMed ID: 18559665
[TBL] [Abstract][Full Text] [Related]
30. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance.
Cremona CA; Sancho R; Diefenbacher ME; Behrens A
Semin Cancer Biol; 2016 Feb; 36():52-61. PubMed ID: 26410034
[TBL] [Abstract][Full Text] [Related]
31. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
32. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.
Arabi A; Ullah K; Branca RM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O
Nat Commun; 2012; 3():976. PubMed ID: 22864569
[TBL] [Abstract][Full Text] [Related]
33. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
[TBL] [Abstract][Full Text] [Related]
34. The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits.
Fekrmandi F; Wang TT; White JH
Sci Rep; 2015 Aug; 5():13002. PubMed ID: 26269414
[TBL] [Abstract][Full Text] [Related]
35. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.
Min SH; Lau AW; Lee TH; Inuzuka H; Wei S; Huang P; Shaik S; Lee DY; Finn G; Balastik M; Chen CH; Luo M; Tron AE; Decaprio JA; Zhou XZ; Wei W; Lu KP
Mol Cell; 2012 Jun; 46(6):771-83. PubMed ID: 22608923
[TBL] [Abstract][Full Text] [Related]
36. Aberrant regulation of FBW7 in cancer.
Wang L; Ye X; Liu Y; Wei W; Wang Z
Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
[TBL] [Abstract][Full Text] [Related]
37. The SV40 large T antigen contains a decoy phosphodegron that mediates its interactions with Fbw7/hCdc4.
Welcker M; Clurman BE
J Biol Chem; 2005 Mar; 280(9):7654-8. PubMed ID: 15611062
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
39. A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function.
Rottmann S; Wang Y; Nasoff M; Deveraux QL; Quon KC
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15195-200. PubMed ID: 16210249
[TBL] [Abstract][Full Text] [Related]
40. Ras activity regulates cyclin E degradation by the Fbw7 pathway.
Minella AC; Welcker M; Clurman BE
Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9649-54. PubMed ID: 15980150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
